Literature DB >> 2215618

Hypercalcemia and ectopic secretion of parathyroid hormone by an ovarian carcinoma with rearrangement of the gene for parathyroid hormone.

S R Nussbaum1, R D Gaz, A Arnold.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2215618     DOI： 10.1056/NEJM199011083231907

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  23 in total

1.  Persistent and moderate hypercalcemia related to an ovarian clear cell adenocarcinoma: Pre- and postoperative parathyroid hormone related-peptide and 1,25-dihydroxyvitamin D3 levels.

Authors:  A Benit; J Allard; J Rimailho; J Fauvel; G Escourrou; D Vezzosi; F Donadille; A Bennet; P Caron
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

Review 2.  Diseases of the parathyroid gland in chronic kidney disease.

Authors:  Hirotaka Komaba; Takatoshi Kakuta; Masafumi Fukagawa
Journal:  Clin Exp Nephrol       Date:  2011-08-06       Impact factor: 2.801

Review 3.  The molecular biology of parathyroid disease.

Authors:  M Backdahl; J R Howe; T C Lairmore; S A Wells
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

Review 4.  "Asymptomatic" and symptomatic primary hyperparathyroidism.

Authors:  J A Fischer
Journal:  Clin Investig       Date:  1993-07

5.  Parathyroid hormone expression in a patient with metastatic nasopharyngeal rhabdomyosarcoma and hypercalcemia.

Authors:  Katy Wong; Shawn Tsuda; Ryan Mukai; Kenneth Sumida; Richard Arakaki
Journal:  Endocrine       Date:  2005-06       Impact factor: 3.633

6.  Primary hyperparathyroidism: epidemiology, diagnosis and clinical picture.

Authors:  S Ljunghall; P Hellman; J Rastad; G Akerström
Journal:  World J Surg       Date:  1991 Nov-Dec       Impact factor: 3.352

Review 7.  Molecular genetics of parathyroid disease.

Authors:  Gunnar Westin; Peyman Björklund; Göran Akerström
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

Review 8.  Denosumab: a new agent in the management of hypercalcemia of malignancy.

Authors:  Sonali Thosani; Mimi I Hu
Journal:  Future Oncol       Date:  2015-09-25       Impact factor: 3.404

9.  Hormonally Functional Ovarian Neoplasms.

Authors:  Lawrence M. Roth; Steven D. Billings
Journal:  Endocr Pathol       Date:  2000       Impact factor: 3.943

Review 10.  Primary hyperparathyroidism.

Authors:  Marcella D Walker; Shonni J Silverberg
Journal:  Nat Rev Endocrinol       Date:  2017-09-08       Impact factor: 43.330
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.